Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-04
DOI
10.3389/fimmu.2021.671325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
- (2020) Kristen A. Clarkson et al. mSphere
- Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study
- (2020) Dani Cohen et al. LANCET INFECTIOUS DISEASES
- A High-throughput Shigella-specific Bactericidal Assay
- (2019) Hailey P. Weerts et al. Jove-Journal of Visualized Experiments
- Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
- (2019) Esther Ndungo et al. Human Vaccines & Immunotherapeutics
- The use and abuse of a 4-fold increase in antibody response to assess immunogenicity in early stage vaccine clinical trials
- (2019) Allan Saul et al. VACCINE
- OUP accepted manuscript
- (2018) JOURNAL OF TRAVEL MEDICINE
- A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei
- (2018) Robert W Frenck et al. VACCINE
- Emergence of antibiotic resistant Shigella species: A matter of concern
- (2018) Minakshi Puzari et al. Journal of Infection and Public Health
- Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay
- (2018) Moon H. Nahm et al. mSphere
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
- (2018) Ibrahim A Khalil et al. LANCET INFECTIOUS DISEASES
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- How Do the Virulence Factors of Shigella Work Together to Cause Disease?
- (2017) Emily Mattock et al. Frontiers in Cellular and Infection Microbiology
- A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
- (2017) Christina W. Obiero et al. Frontiers in Immunology
- Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
- (2017) Odile Launay et al. EBioMedicine
- Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout
- (2017) Francesca Necchi et al. PLoS One
- A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity
- (2016) Robert M. F. van der Put et al. BIOCONJUGATE CHEMISTRY
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study
- (2016) Avital A. Shimanovich et al. Clinical and Vaccine Immunology
- Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century
- (2016) Mark Anderson et al. Frontiers in Cellular and Infection Microbiology
- Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)
- (2015) James A Platts-Mills et al. Lancet Global Health
- Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB
- (2015) Christiane Gerke et al. PLoS One
- Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a
- (2013) Rezwanul Wahid et al. CLINICAL IMMUNOLOGY
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Analysis of Different Prognostic Indicators for Malnutrition and Shigella flexneri Infection Among the Children in Bangladesh
- (2012) M. Murshida Mahbub et al. INDIAN JOURNAL OF MICROBIOLOGY
- Differential Host Immune Responses to Epidemic and Endemic Strains of Shigella dysenteriae Type 1
- (2011) Mohammad Abu Sayem et al. JOURNAL OF HEALTH POPULATION AND NUTRITION
- Changing species distribution and antimicrobial susceptibility pattern of Shigella over a 29-year period (1980–2008)
- (2010) F. KHATUN et al. EPIDEMIOLOGY AND INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now